News
MedStandard Rus
Monday 27 March
M&A processes in healthcare will intensify in 2023
Mergers and acquisitions (M&A) activity in the healthcare sector should recover in 2023 after a difficult macroeconomic and political situation, rising inflation, follows from the PWC forecast (https://www.pwc.com/gx/en/services/deals/trends/health-industries.html ). This trend is also noted in the Russian market, the participants of the CEO Summit Medicine noted.
Special mechanisms have been introduced to overcome the shortage of medicines and medical products. There is no global deficit in the country now, the Ministry of Health reported.
500 million rubles for the development of medicines and medical products
The government has allocated over 503 million rubles for the development and creation of products and medicines based on cellular technologies and tissue engineering technologies. The money will be allocated within the framework of the federal project “Medical Science for Man”.
More news: https://medstandard.ru/news/